West Virginia University Logo

September 24, 2014


SAMHSA Prescription Drug Abuse Weekly Update
Issue 90  |  September 24, 2014
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional Education News Other State and Local News Other Resources Webinar Webinar Archive Grant Awarded Audio Video Request for Proposal National Take-Back Event Take-Back Events and Drop Boxes Upcoming Conferences and Workshops


L.H. Chen, H. Hedegaard, and M. Warner. 2014. "Drug-Poisoning Deaths Involving Opioid Analgesics: United States, 1999–2011." NCHS Data Brief, No. 166. Hyattsville, Md.: National Center for Health Statistics.

This update on opioid-analgesic poisoning deaths found the age-adjusted rate nearly quadrupled from 1.4 per 100,000 in 1999 to 5.4 per 100,000 in 2011. Although opioid-analgesic poisoning deaths have increased each year from 1999 through 2011, the rate of increase has slowed since 2006. (Editor's note: The average annual increase in deaths has not slowed and was almost 1.5 times higher from 2006 to 2011 than from 1999 to 2006.) Natural and semisynthetic opioid analgesics were involved in 11,693 drug poisoning deaths in 2011—up from 2,749 deaths in 1999 and 10,943 deaths in 2010. Benzodiazepines were involved in 31 percent of these deaths in 2011—up from 13 percent in 1999. During the past decade, the greatest increase in opioid-analgesic poisoning death rates was among adults aged 55–64 and non-Hispanic white persons.

Read more:

Prescription Drug Monitoring Program Center of Excellence at Brandeis. 2014. "Briefing on PDMP Effectiveness."

The Prescription Drug Monitoring Program (PDMP) Center of Excellence at Brandeis has released a newly updated "Briefing on PDMP Effectiveness." First issued in 2012 with 35 references, the current version cites more than 60 sources, including research studies, evaluations, surveys, and other reports. These provide evidence supporting the conclusion that PDMPs are effective tools in addressing the prescription drug abuse epidemic. The briefing identifies the following areas in which PDMPs can play a significant role: improving clinical decision making and patient care; identifying and reducing doctor shopping and other diversion; reducing inappropriate prescribing and associated drug and medical costs; reducing prescription drug investigation times; monitoring compliance in drug courts and other criminal justice programs; assisting in substance abuse treatment; assisting medical examiners and coroners; and assisting in drug abuse prevention and surveillance efforts. Data described in the briefing also suggest PDMPs are contributing to improvements in health outcomes, including declines in overdose deaths, emergency department visits, and treatment admissions related to prescription opioids.

Read more:

Journal Articles and Reports

S.M. Bagley, E.M. Wachman, E. Holland, and S.B. Brogly. 2014. "Review of the Assessment and Management of Neonatal Abstinence Syndrome." Addiction Science and Clinical Practice 9:19, doi:10.1186/1940-0640-9-19.

This systematic review examines evidence for neonatal abstinence syndrome (NAS) assessment tools, nonpharmacologic interventions, and pharmacologic management of opioid-exposed infants. Due to the lack of a standardized approach, limited data exist on the interobserver reliability of NAS assessment tools. In addition, most scales were developed prior to the widespread use of prescribed prenatal concomitant medications that complicate neonatal assessment. Nonpharmacologic interventions, particularly breastfeeding, may decrease NAS severity. Morphine and methadone are recommended as first-line therapy for NAS, with phenobarbital and clonidine as second-line adjunctive therapy.

Read more:

J.A. Crocker, H. Yu, M. Conaway, A.G. Tuskey, and B.W. Behm. 2014. "Narcotic Use and Misuse in Crohn's Disease." Inflammatory Bowel Diseases. Epub ahead of print.

A retrospective chart review of patients with Crohn's disease followed at the University of Virginia's Gastroenterology Clinic from 2006 to 2011 was combined with longitudinal data from the prescription drug monitoring program. Narcotic misuse was defined as filling narcotic prescriptions from four or more prescribers at four or more different pharmacies. Of 931 patients with Crohn's disease, 9 percent had a concurrent functional gastrointestinal disorder (FGID), and 20 percent were on chronic narcotics. Patients with an FGID were more likely to be taking chronic narcotics (44 percent versus 18 percent). Most chronic users were misusing the drugs, including 37 percent of all patients with an FGID and 10 percent of other patients.

Read more:

T. Gomes, M.M. Mamdani, J.M. Paterson, I.A. Dhalla, and D.N. Juurlink. 2014. "Trends in High-Dose Opioid Prescribing in Canada." Canadian Family Physician 60(9):826–32.

From 2006 to 2011, the rate at which Canadian retail pharmacies dispensed high-dose opioid formulations increased 23 percent—from 781 to 961 units per 1,000 population. Dispensing rates remained relatively stable in Alberta (with a 6 percent increase) and British Columbia (with an 8 percent increase). Rates rose substantially in Newfoundland and Labrador (85 percent) and Saskatchewan (54 percent). Ontario had the highest annual rate of high-dose oxycodone and fentanyl dispensing (756 tablets and 112 patches per 1,000 population, respectively), while Alberta's rate of high-dose morphine dispensing was the highest in Canada (347 units per 1,000 population). The highest rates of high-dose hydromorphone dispensing were found in Saskatchewan and Nova Scotia (258 and 369 units per 1,000 population, respectively). Quebec had the lowest rate of high-dose oxycodone and morphine dispensing (98 and 53 units per 1,000 population, respectively).

Read more:

B.C. Kelly, H.J. Rendina, M. Vuolo, B.E. Wells, and J.T. Parsons. 2014. "A Typology of Prescription Drug Misuse: A Latent Class Approach to Differences and Harms." Drug and Alcohol Review, doi:10.1111/dar.12192.

Continuing their analysis of data from 404 young adults recruited at nightlife locales in New York City, researchers used latent class analysis to classify prescription drug misusers as dabblers, primary stimulant users, primary downers users, and extensive regular users. No demographic differences existed between groups. Predictably, extensive regular users reported the most symptoms related to dependence, the most problems related to misuse, and the most mental health problems, while dabblers reported the fewest.

Read more:

M.C. Lovegrove, J. Mathew, C. Hampp, L. Governale, D.K. Wysowski, and D.S. Budnitz. 2014. "Emergency Hospitalizations for Unsupervised Prescription Medication Ingestions by Young Children." Pediatrics, doi:10.1542/peds.2014-0840.

From 2007 to 2011, roughly 9,500 emergency hospitalizations occurred annually in the United States for unsupervised prescription medication ingestion by children under 6. About 75 percent of patients involved 1- or 2-year-old children. Opioids (18 percent) and benzodiazepines (10 percent) were the most commonly implicated medication classes. The most commonly implicated active ingredients were buprenorphine (8 percent) and clonidine (7 percent). Accounting for the number of patients who received dispensed prescriptions, the hospitalization rate for unsupervised ingestion of buprenorphine products was significantly higher than the rate for any other commonly implicated medications, and 97-fold higher than the rate for oxycodone products (200 versus 2 hospitalizations per 100,000 unique patients). To make these estimates, the authors combined 2007–11 adverse drug event data from the National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance project with national retail pharmacy dispensing data from IMS Health.

Read more:

C. Ruetsch. 2014. "Treating Prescription Opioid Dependence." JAMA, 312(11):1145–46, doi:10.1001/jama.2014.4318.

The author comments on "A Randomized, Double-Blind Evaluation of Buprenorphine Taper Duration in Primary Prescription Opioid Abusers," a 2013 study in JAMA Psychiatry. Normally, opioid treatment involves a regimen of at least 6 months. In this small, 12-week randomized clinical trial (Editor's note: essentially, this was just a pilot study), following a brief period of buprenorphine stabilization, 70 prescription opioid–dependent adults were randomized to receive 1-, 2-, or 4-week tapers followed by naltrexone therapy through week 12. Participants visited the outpatient clinic daily for behavioral therapy and urine toxicology testing through week 5, and three times weekly in weeks 6–12. Opioid abstinence was 63 percent for the 4-week taper, compared with 29 percent for 1- or 2-week tapers at the end of week 5, and 50 percent versus 18 percent at the end of week 12. Retention and naltrexone ingestion were also superior in the 4-week versus briefer tapers. These short-term abstinence rates were lower than rates observed with longer treatment regimens, and no data are available on abstinence at 6 months. The sample was too small to analyze which patient or clinician characteristics, if any, contributed to treatment success.

Read more:

L–T. Wu, M.S. Swartz, K.T. Brady, D.G. Blazer, and R.H. Hoyle. 2014. "Nonmedical Stimulant Use Among Young Asian Americans, Native Hawaiians/Pacific Islanders, and Mixed-Race Individuals Aged 12–34 Years in the United States." Journal of Psychiatric Research, doi:10.1016/j.jpsychires.2014.09.004.

Among respondents 12–34 years old in the 2005–12 National Surveys on Drug Use and Health, significant yearly increases in lifetime nonmedical stimulant use occurred among whites, but not among Native Hawaiians/Pacific Islanders. Mixed-race individuals did not differ from whites in prevalence, but Asian Americans had a lower prevalence. In each racial/ethnic group, females had greater odds than males of nonmedical stimulant use. Other substance use increased odds of nonmedical stimulant use and disorder.

Read more:

Professional Education

N. Amoore. 2014. "Over the Counter, Under the Radar: Opioid Analgesic Abuse in South Africa." Mental Health Matters 1(2):33–37.

Opioid dependence has been flagged as a significant contributor to the global burden of disease. This article points to the increased incidence in Sub-Saharan Africa.

Read more:

CDC Reports Alarming Stats on Prescription Painkillers
Megan Brooks, Medscape
Continuing Medical Education/Continuing Education released September 12, 2014; valid for credit through September 12, 2015

This activity is intended for primary care clinicians, pain specialists, neurologists, surgeons, pharmacists, nurses, and other clinicians who prescribe opioid or narcotic pain relievers. Upon completion, participants will be able to describe recent statistics from the Centers for Disease Control and Prevention (CDC) on opioid and narcotic analgesic use and discuss the CDC's recommendations.

Read more:


Taking the Fight Against the Deadly Prescription Drug Epidemic Online
Jason Millman, The Washington Post
September 12, 2014

A March 2010 Drug Enforcement Administration rule allowed pharmacies and care providers to handle prescriptions for Schedule II–V controlled substances entirely online. As a result, the Electronic Prescribing for Controlled Substances (EPCS), an online tracking system of powerful and potentially addictive drugs, was launched. Some experts think the EPCS could help deter prescription drug abuse and fraud. It reduces reliance on paper, hampering the opportunity for forged prescriptions, and creates a new route for identifying potential cases of misuse. DrFirst, a leading vendor of EPCS technology, reports the company's EPCS transactions increased from about 11,000 per month in January 2013 to 60,000 in July 2014. Starting in March 2015, New York will be the first state restricting controlled substances to electronic prescriptions only.

Read more:

Nearly 10% of Americans Go to Work High on Weed
Yohana Desta, Mashable
September 17, 2014

In a Mashable survey with 534 self-selected U.S. respondents, 28.3 percent admitted going to work under the influence of prescription drugs, and 7.3 percent said they took the drugs for recreational rather than medicinal purposes. More than 95 percent of users legally acquired the drugs through a doctor's prescription.

Read more:

Fears Rise of Medication Misuse by the Elderly
Barbara Sadick, The Wall Street Journal
September 14, 2014

David Oslin, a psychiatry professor at the University of Pennsylvania's Perelman School of Medicine, said medication use is a rising problem among seniors as the baby boom generation ages. Physicians sometimes fail to recognize a history of addiction or potential for addiction. Longtime use may diminish a drug's effects, and when two or more medications are combined, it may cause adverse reactions. Experts in senior care are working to raise awareness of the problem among patients and healthcare providers. For example, the American Geriatrics Society is updating its Beers Criteria for determining which medications are potentially inappropriate for seniors.

Read more:

Workers Comp Industry Needs Strategies to Combat Opioid Abuse: Panel
Bill Kenealy, Business Insurance
September 11, 2014

Presenters at the 2014 California Workers' Compensation and Risk Conference said workers' compensation professionals need a comprehensive strategy to address the risk of opioid abuse. Patti Williams, risk manager for the City of Huntington Beach, said a team-based approach was best to ensure patients don't become addicted to their prescriptions. The city has invested in a nurse case manager.

Read more:

Stopping America's Hidden Overdose Crisis
Joan Marcus, MSN
September 16, 2014

Doctor shopping is one reason why drug overdoses have become the leading cause of injury death in the United States. Many states have prescription drug monitoring programs but differ in protocols, including whether doctors are required to check the database before prescribing opioids. Recently, the Veterans Administration agreed to report its patients' prescription histories to state registries or check prescriptions from outside providers. The most effective measure would be a national registry. However, some people think such a registry would only catch the most egregious doctor shoppers. Also, doctors might not know what to do with the information.

Read more:

5 Ways to Thwart Illegal Drug Dealing Online
Ford Vox, Scientific American
September 12, 2014

Dr. Ford Vox, a physician who practices brain injury medicine at the Shepherd Center, shares five ways to prevent online drug dealing: 1) merging online drug trade enforcement into a single agency with an assigned program head; 2) getting eCommerce companies to recognize their obligations to avoid activities for which they are unlicensed; 3) providing nonpharmacy retailers an easily navigable "Do Not Sell" list from the Food and Drug Administration; 4) making it illegal to sell prescription drugs via Web domains other than .pharmacy; and 5) using the recent FedEx indictment as a model for pursuing online retailers engaged in questionable drug deals.

Read more:

Adderall the New Drug of Choice for Many Major-Leaguers
Gregg Doyel, CBS Sports
September 12, 2014

Major League Baseball (MLB) players are abusing Adderall. Doctors estimate 4.4 percent of the general adult population suffers from attention deficit hyperactivity disorder, but this season 9.9 percent of MLB players presented notes from their doctors saying they required Adderall. Kansas City physician Avner Stern says he has rejected Adderall requests from professional ballplayers. One offered him money for a script.

Read more:

Big Cities Take Aim at Prescription Painkillers
Matthew Perrone, ABC News
September 16, 2014

Recently, health commissioners from Chicago, New York, and Boston went to Washington to lobby Congress and the White House on efforts to combat prescription opioid abuse. Dr. Bechara Choucair, Chicago's health commissioner, said big cities are feeling the brunt of the problem. Chicago filed a lawsuit in July that alleges five pharmaceutical companies deceptively marketed their drugs to treat long-term, non-cancer pain, even though that use was "unsupported by science." Drug makers have asked a U.S. district judge to dismiss the suit due to the lack of specific instances of fraud.

Read more:

Other State and Local News

Rockland County Officials Announce Community Action Plan Targeting Heroin and Prescription Drug Abuse
Michael Riconda, Rockland County Times
September 18, 2014

Rockland County, N.Y., will pursue a three-pronged plan to combat recent surges in heroin and prescription drug abuse. The plan includes integrating targeted enforcement of the law to remove drug traffickers, providing treatment through legal and medical channels, and conducting an education campaign for prosecutors, law enforcement, educators, and students.

Read more:

Five Correctional Officers, an Inmate, and a Drug Supplier Plead Guilty in Baltimore Jail Racketeering Conspiracy
Federal Bureau of Investigation
September 12, 2014

U.S. District Judge Ellen L. Hollander sentenced several Baltimore City Detention Center correctional officers who smuggled contraband like prescription drugs, marijuana, and tobacco into the jail for the Black Guerilla Family. To date, 34 of the 44 defendants charged in the conspiracy have pleaded guilty, including 21 correctional officers. One defendant has died. For the remaining defendants, trial is scheduled to begin November 17, 2014.

Read more:

N.J. Lawmakers Set to Combat Heroin, Opiate Abuse
Dustin Racioppi, Asbury Park Press
September 17, 2014

New Jersey lawmakers unveiled 21 bills that address heroin and prescription drug abuse. The Overdose Protection Act would expand availability of naloxone to include substance abuse workers and volunteers, and would require those who administered the antidote to provide the patient with overdose prevention information. Other bills include updating how abuse and addiction are taught in schools, allowing medication-based therapies in the drug court system, expanding Project Medicine Drop locations, and requiring the state Poison Control Center to establish a clearinghouse of drug overdose information.

Read more:

Prescription Drug Deaths Slowing, but More Can Be Done
Saerom Yoo, Statesman Journal
September 16, 2014

An Oregon Health Authority report found that between 2000 and 2012, 4,182 residents died from drug overdoses. One third of the deaths involved prescription opiates, and the majority involved some type of prescribed medication. The report recommends more monitoring of patients receiving opiates for chronic noncancer pain. In June, staff at physicians' offices gained access to Oregon's prescription drug monitoring program.

Read more:

N.M. Drug Overdose Death Rate Down 16 Percent
The Taos News
September 17, 2014

The New Mexico Department of Health Bureau of Vital Records and Health Statistics reported drug overdose deaths among the state's residents have decreased 16 percent from 2011 to 2013 (25.9 to 21.8 per 100,000 population).

Read more:

Ohio's Heroin Epidemic Requires a Comprehensive Response: Rob Portman
Rob Portman, Cleveland.com
September 17, 2014

Ohio Senator Rob Portman discusses a comprehensive plan to address drug overdose and addiction. His first step is to introduce the Comprehensive Addiction and Recovery Act of 2014, legislation that includes prevention, law enforcement strategies, expansion of evidence-based treatment, and support for those in or seeking recovery.

Read more:

As Staten Island Battles Drug Overdoses, Are Local Solutions the Answer?
Anna Sanders, Staten Island Advance
September 16, 2014

VOCAL New York, a statewide advocacy group that aims to build power among low-income communities, recently organized a rally to gather support for combatting the drug overdose epidemic. The group released a state policy platform calling for more safe injection facilities and more access to evidence-based drug treatment and naloxone. It wants the city and state to double funding for harm reduction programs.

Editor's note: According to the Drug Policy Alliance, supervised injection rooms are legally sanctioned facilities where people who use intravenous drugs can inject pre-obtained drugs under medical supervision. These facilities are designed to reduce the health and societal problems associated with injection drug use.

Read more:

St. Clair County Urging Doctors to Fight Prescription Drug Abuse
Ruella Rouf, KMOV
September 15, 2014

Brendan Kelly, St. Clair County State's Attorney, and Dr. Steve Morton, The Medical Society President, sent a letter to doctors urging them to use the Illinois prescription drug monitoring program. (Video included: 2:06 minutes)

Read more:

Mobile Unit Battles Clark County Rx Drug Abuse
Allison Wichie, Dayton Daily News
September 15, 2014

The Clark County Sheriff's Office has converted a van into a mobile prescription drug take-back unit—possibly the first in Ohio. Now people can turn in unwanted prescriptions without going to a public safety building.

Read more:

Dade County Sheriff's Office Offering Free Drug Testing for Kids
Erik Avanier, WDEF
September 17, 2014

Georgia's Dade County Sheriff's Office is now offering free drug tests to parents who suspect their child is taking illegal or prescription drugs. Parents can bring their child to the jail for the deputy-administered drug test. The child would be asked to provide a urine sample, which would show everything from marijuana to prescription narcotics. If positive, an arrest would not be made, but the child's parent would be given a referral to find help. (Video included: 1:54 minutes)

Read more:

Addicted Elders an Emerging Problem
K.C. Myers, Cape Code Times
September 13, 2014

At the 27th annual Cape Cod Symposium on Addictive Disorders, John Dyben, director of spiritual care and wellness for the Hanley Center, said seniors struggle with substance dependence. Alcohol, opiate pain relievers, and benzodiazepines top the list. Dyben said doctors rarely screen for alcohol or drug dependence when an elderly person seeks treatment, and seniors who become injured or complain about pain are often prescribed addictive opiates. If they get hooked, it is easy for them to doctor shop or obtain prescription refills. Cape Cod, which has the highest median age in Massachusetts (51.4 years), now employs counselors at several primary care doctors' offices to screen patients for mental health problems and addiction.

Read more:

Some Teen Athletes Becoming New Face of Addiction in Mass.
Karen Anderson, WCVB
September 15, 2014

Tristin Pierce became addicted to Percocet after being offered the medication by a fellow football player. He started using heroin when Percocet became too expensive and, several years later, overdosed and died. Hillary Jacobs at the Department of Public Health said most adolescents in Massachusetts detox programs are addicted to heroin and opiates. (Includes video: 2:47 minutes)

Read more:

UM Football Student Manager Dies from an Overdose at 22
John Streckroth, The Michigan Journal
September 16, 2014

On June 20, 2014, 22-year-old Joshua Evan Levine, a University of Michigan graduate and former student manager of the football team, died from mixing alcohol and Adderall.

Read more:

Health Officials Respond: 'Opioids Not as Safe as Thought'
Mary Beth Pfeiffer, Poughkeepsie Journal
September 14, 2014

The New York State Department of Health responds to Poughkeepsie Journal questions about opioid pain reliever prescribing and oversight of physician misconduct. The statement addresses activities of the Office of Professional Medical Conduct, which monitors 90,000 physicians and 10,000 licensed state physician assistants.

Read more:

Other Resources

National Drug Facts Week
January 26–February 1, 2015

National Drug Facts Week is a countrywide health observance when teens can promote local events incorporating National Institute on Drug Abuse science to shatter drug myths. This guide provides everything needed to plan, promote, and host an event.

Read more:


Addressing Opioid Misuse and Abuse: ONDCP and SAMHSA Partnership to Reduce Risk of Overdose
American Psychiatric Association
September 30, 2014
12 to 1 p.m. EST

This Webinar will review federal policy on opioid misuse, abuse, and overdose, and provide an overview of SAMHSA's Opioid Overdose Prevention Toolkit. It will also address the etiology of opioid abuse and clinician interventions that can reduce the risk of misuse.

Read more:

Webinar Archive

Evidence-Based and Promising Workplace Programs to Prevent Prescription Drug Abuse
SAMHSA Preventing Prescription Abuse in the Workplace Project
June 16, 2014

This Webinar described four workplace prescription abuse prevention programs and key replicable programmatic factors for successfully addressing prescription abuse in the workplace.
(Duration: 1:34:47)

Read more:

Grant Awarded

Injury Research Center Gets CDC Grant
Victoria Mirian, The Daily Tar Heel
September 18, 2014

The University of North Carolina Injury Prevention Research Center received a $4.5 million grant from the Centers for Disease Control and Prevention. This continuation of funding to conduct four studies on preventing various types of injuries includes a project by Christopher Ringwalt, a University of North Carolina health behavior adjunct professor, who will look at the prescription drug monitoring program to determine if recently mandated changes to state law have affected prescription drug abuse.

Read more:


Surviving Steroids: The Dark Side of Performance-Enhancing Drugs
September 13, 2014

Eugene Robinson, Ozy.com deputy editor, talks with NPR's Arun Rath about past experiences with performance-enhancing drugs and the "dark side" of steroids. (Duration: 3:29 minutes, includes transcript)


What Parents Should Know About Prescription Drug Abuse: Your Teen's Health Podcast Series #4
Kate Wornock, Blue Cross and Blue Shield of Florida
September 12, 2014

Carmella Sebastian, Florida Blue's senior medical director, shares advice on what parents can do to protect teens from prescription drug abuse. (Duration: 9:13 minutes, includes transcript)



Secret Life of Teens: The Dangerous Drug Parents Aren't Talking About with Kids
A. Pawlowski, Today
September 19, 2014

NBC special anchor Maria Shriver talks to Cyrus Stowe, the 17-year-old Texas student who created Out of Reach, a documentary about students abusing prescription drugs. Shriver also interviews a mother whose son accidentally overdosed on pain relievers, leaving him with permanent brain damage. The article features advice from the Partnership for Drug-Free Kids for preventing teen prescription drug abuse. (Duration: 3:50 minutes)


Request for Proposal

Chronic Pain Management Research Grant
Milbank Foundation
Postmarked by November 1, 2014

Interventions for Youth Who Misuse/Abuse Prescription Stimulant Medications in High School and/or College-Attending Youth (U01)
National Institutes of Health
Deadline: November 13, 2014, by 5 p.m.

National Take-Back Event

National Take-Back Initiative
Drug Enforcement Administration
September 27, 2014
Various locations nationwide

Take-Back Events and Drop Boxes

Brownwood Police Department Receives Medication Disposal Unit Through CVS Grant
Lisa Tipton, Brownwood News (Texas)
September 15, 2014

Chief's Chat: New Drug Collection Unit at the Police Department
The St. James Leader Journal (Missouri)
September 16, 2014

Drug Disposal Day Planned for October 11
NBC4i (Ohio)
September 18, 2014

New Prescription Drug Drop Off Box in Livingston County
WHEC (New York)
September 16, 2014

Upcoming Conferences and Workshops

5th Annual Prescription Drug Abuse Symposium: Reversing the Tide of Opioid Abuse
Office of the Indiana Attorney General
October 16–17, 2014
Indianapolis, Indiana

Empowered Health Consciousness and Prescription Drugs: Facilitator Certification Training with Special Focus on Workplace and Parents
Organizational Wellness
November 4, 2014

Sixth Annual American Medicine Chest Challenge: National Day of Awareness and Safe Disposal of Rx and OTC Medicine
American Medicine Chest Challenge
November 8, 2014

142nd Annual Meeting and Exposition
American Public Health Association
November 15–19, 2014
New Orleans, Louisiana

National Rx Drug Abuse Summit
April 6–9, 2015
Atlanta, Georgia
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.